Ambac Financial Group has officially rebranded as Octave Specialty Group, marking its transformation into a dedicated specialty insurance platform. The company will begin trading on the New York Stock ...

NEW YORK - Ambac Financial Group, Inc. (NYSE:AMBC) announced Monday it is rebranding to Octave Specialty Group, Inc. as part of its strategic transformation into a specialty insurance platform. The ...

Imelda and Humberto have both dissipated in the Atlantic, but the National Hurricane Center is tracking another storm, Tropical Storm Humberto, in the Pacific. Tropical Storm Octave is spinning over ...

Editor's Note: Tropical Storm Octave continues on its path. See the latest update for Friday, October 3. As the National Hurricane Center tracks Imelda, now a post-tropical cyclone in the Atlantic, a ...

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. This satellite image provided by the National ...

This storm is no longer being tracked. Octave was a post-tropical cyclone in the North Pacific Ocean Thursday morning Pacific time, the National Hurricane Center said in its latest advisory. Octave is ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a commercial stage precision care company that is pioneering a new standard for managing multiple sclerosis (MS) and other ...

Two fast-growing artificial intelligence companies are betting that the future of sales lies not in hiring more salespeople, but in creating an entirely new type of professional that combines revenue ...

While it is easy to convert JD-800 patches to use with the JD-990 (the JD-990 itself can do it through RAM card exchange, and there are PC tools for it as well), there don't appear to be any tools to ...

Need to separate bolts that arrive in a mixed batch onsite? Hexagon's Aeon robot can do that. Aeon's human friend is 'seeing' items in front of it with head-mounted cameras through NVIDIA Omniverse.

Octave Bioscience’s Multiple Sclerosis Disease Activity (MSDA) test, which uses data from blood biomarkers to assess multiple sclerosis (MS) disease activity, is now available across all 50 U.S.